Showing results (201-210 of 610) with videos related to

Sort By:
Pageof 61
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 22, 2025
Patient-specific susceptibility to the nadir oxygen delivery on cardiopulmonary bypassMartina Anguissola, Alessandro Barbaria, Roberto Ferrari, et al.
Epigenetics|November 1, 2013
A unique epigenetic signature is associated with active DNA replication loci in human embryonic stem cellsBing Li, Trent Su, Roberto Ferrari, et al.
Molecular Systems Biology|December 20, 2007
Modeling the regulatory network of histone acetylation in Saccharomyces cerevisiaeHung Pham, Roberto Ferrari, Shawn J Cokus, et al.
Journal of the American College of Cardiology|March 4, 2014
Transradial coronary catheterization and intervention across the whole spectrum of Allen test resultsMarco Valgimigli, Gianluca Campo, Carlo Penzo, et al.
Pacing and Clinical Electrophysiology : PACE|May 30, 2008
Paroxysmal atrial fibrillation ablation with the multipolar mapping and ablation catheter (Mesh-Bard)Claudio Pratola, Pasquale Notarstefano, Paolo Artale, et al.
Platelets|April 7, 2016
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registrySimone Biscaglia, Gianluca Campo, Rita Pavasini, et al.
Current Heart Failure Reports|September 26, 2020
Current Role of Echocardiography in Cardiac Resynchronization Therapy: from Cardiac Mechanics to Flow Dynamics AnalysisDonato Mele, Filippo Trevisan, Andrea Fiorencis, et al.
Cytokine|June 2, 2005
Acute haemodynamic effects of IL-6 treatment in vivo: involvement of vagus nerve in NO-mediated negative inotropismLaura Comini, Evasio Pasini, Tiziana Bachetti, et al.
Atherosclerosis|March 18, 2010
Metalloproteinase 2 cleaves in vitro recombinant TRAIL: potential implications for the decreased serum levels of TRAIL after acute myocardial infarctionPaola Secchiero, Arianna Gonelli, Federica Corallini, et al.
European Journal of Pharmacology|August 25, 2007
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACEClaudio Ceconi, Gloria Francolini, Adriana Olivares, et al.
Pageof 61